{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:15:26Z","timestamp":1777364126244,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-025-00822-9","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:55:15Z","timestamp":1767801315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["2 cases of pegylated asparaginase-associated cerebral venous sinus thrombosis in children: clinical analysis and literature review"],"prefix":"10.1186","volume":"24","author":[{"given":"Meijun","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanwen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongxian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengbin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"issue":"S2","key":"822_CR1","doi-asserted-by":"publisher","first-page":"e28371","DOI":"10.1002\/pbc.28371","volume":"68","author":"JH Chang","year":"2021","unstructured":"Chang JH, Poppe MM, Hua CH, Marcus KJ, Esiashvili N Acute lymphoblastic leukemia. Pediatr Blood Cancer. 2021;68(S2):e28371. https:\/\/doi.org\/10.1002\/pbc.28371.","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"822_CR2","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.3390\/jcm10091926","volume":"10","author":"H Inaba","year":"2021","unstructured":"Inaba H, Pui CH. Advances in the diagnosis and treatment of pediatric acute lymphoblastic leukemia. J Clin Med. 2021;10(9):1926. https:\/\/doi.org\/10.3390\/jcm10091926. Published 2021 Apr 29.","journal-title":"J Clin Med"},{"key":"822_CR3","unstructured":"Ma J, Shen ZX, Zhu J, et al. Expert consensus on the use of Pegaspargase in the treatment of acute lymphoblastic leukemia and malignant lymphoma in China. Chin J Oncol Med. 2015;24(1):1-7. DOI: CNKI:SUN:ZGZL.0.2015-24-001."},{"key":"822_CR4","doi-asserted-by":"publisher","unstructured":"Li S, Lu XT, Hua Y, et al. Clinical study of asparaginase therapy in children with acute lymphoblastic leukemia. Chin J Pediatr Hematol Oncol. 2017;1:15-20. https:\/\/doi.org\/10.3969\/j.issn.1673-5323.2017.01.006","DOI":"10.3969\/j.issn.1673-5323.2017.01.006"},{"key":"822_CR5","doi-asserted-by":"publisher","unstructured":"Shimony S, Raman HS, Flamand Y, et al. Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen. Blood Cancer J. 2024;14(1):191. https:\/\/doi.org\/10.1038\/s41408-024-01178-5","DOI":"10.1038\/s41408-024-01178-5"},{"issue":"8","key":"822_CR6","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1016\/j.clml.2020.04.001","volume":"20","author":"WFD Silva","year":"2020","unstructured":"Silva WFD, Massaut IHB, Bendlin RM, et al. Toxicity profile of PEG-Asparaginase in adult patients with acute lymphoblastic leukemia in brazil: A multicenter Cross-Sectional study. Clin Lymphoma Myeloma Leuk. 2020;20(8):e523\u20138. https:\/\/doi.org\/10.1016\/j.clml.2020.04.001.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"822_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/BLCTT.S245210","volume":"11","author":"C Bender","year":"2021","unstructured":"Bender C, Maese L, Carter-Febres M, et al. Clinical utility of Pegaspargase in Children, adolescents and young adult patients with acute lymphoblastic leukemia: A review. Blood Lymphat Cancer. 2021;11:25\u201340. https:\/\/doi.org\/10.2147\/BLCTT.S245210.","journal-title":"Blood Lymphat Cancer"},{"issue":"3","key":"822_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3969\/j.issn.1674-1129.2023.03.014","volume":"41","author":"JT Wang","year":"2023","unstructured":"Wang JT, Du YG, Wang L, et al. The efficacy of PEG-Asp and L-Asp in treating childhood acute lymphoblastic leukemia and their effects on children\u2019s coagulation function [J]. Lab Med Test. 2023;41(3):297\u20139. https:\/\/doi.org\/10.3969\/j.issn.1674-1129.2023.03.014.","journal-title":"Lab Med Test"},{"key":"822_CR9","doi-asserted-by":"publisher","unstructured":"Yan YY, Liu HY, Yu LH, et al. Clinical analysis of 8 cases of cerebral venous sinus thrombosis caused by Pegaspargase. Chin J Neuromed. 2022;21(5):372-377. https:\/\/doi.org\/10.3760\/cma.j.cn115354-20220211-00074.","DOI":"10.3760\/cma.j.cn115354-20220211-00074"},{"key":"822_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.thromres.2019.04.011","volume":"178","author":"MK Mateos","year":"2019","unstructured":"Mateos MK, Trahair TN, Mayoh C, et al. Risk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemia. Thromb Res. 2019;178:132\u20138. https:\/\/doi.org\/10.1016\/j.thromres.2019.04.011.","journal-title":"Thromb Res"},{"key":"822_CR11","doi-asserted-by":"publisher","unstructured":"Zheng Y, Yang W, Estepp J, Pei D, Cheng C, Takemoto CM, Inaba H, Jeha S, Pui CH, Relling MV, Karol SE. Genomic analysis of venous thrombosis in children with acute lymphoblastic leukemia from diverse ancestries. Haematologica. 2023 Jul 6. https:\/\/doi.org\/10.3324\/haematol.2022.281582 . Epub ahead of print. PMID: 37408475.","DOI":"10.3324\/haematol.2022.281582"},{"issue":"1","key":"822_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.beha.2009.01.003","volume":"22","author":"U Nowak-G\u00f6ttl","year":"2009","unstructured":"Nowak-G\u00f6ttl U, Kenet G, Mitchell LG. Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment. Best Pract Res Clin Haematol. 2009;22(1):103\u201314. https:\/\/doi.org\/10.1016\/j.beha.2009.01.003.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"822_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3969\/j.issn.1673-5323.2025.02.009","volume":"30","author":"XR Chen","year":"2025","unstructured":"Chen XR, Tang JH, Xiao X, et al. Clinical analysis of acute lymphoblastic leukemia complicated with cerebral venous sinus thrombosis [J]. Chin J Pediatr Hematol Oncol. 2025;30(2):121\u20136. https:\/\/doi.org\/10.3969\/j.issn.1673-5323.2025.02.009.","journal-title":"Chin J Pediatr Hematol Oncol"},{"issue":"4","key":"822_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3969\/j.issn.1673-5323.2024.04.008","volume":"29","author":"XM Guo","year":"2024","unstructured":"Guo XM, Sun L, Zhang YY. Four cases of intracranial venous sinus thrombosis concurrent with chemotherapy in children with acute lymphoblastic leukemia in the early stage [J]. Chin J Pediatr Hematol Oncol. 2024;29(4):261\u20133. https:\/\/doi.org\/10.3969\/j.issn.1673-5323.2024.04.008.","journal-title":"Chin J Pediatr Hematol Oncol"},{"issue":"4","key":"822_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11547-016-0630-9","volume":"121","author":"C Carducci","year":"2016","unstructured":"Carducci C, Colafati GS, Fig\u00e0-Talamanca L, et al. Cerebral sinovenous thrombosis (CSVT) in children: what the pediatric radiologists need to know. Radiol Med. 2016;121(4):329\u201341. https:\/\/doi.org\/10.1007\/s11547-016-0630-9.","journal-title":"Radiol Med"},{"issue":"11","key":"822_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.12010\/j.issn.1673-5846.2024.11.016","volume":"19","author":"S Jiao","year":"2024","unstructured":"Jiao S. The efficacy and impact on coagulation function of panethinase in children with acute lymphoblastic leukemia [J]. Chin J Drug Econ. 2024;19(11):80\u20133. https:\/\/doi.org\/10.12010\/j.issn.1673-5846.2024.11.016.","journal-title":"Chin J Drug Econ"},{"key":"822_CR17","doi-asserted-by":"publisher","unstructured":"George C, Rahman M, Monagle P. Challenges and opportunities in the pharmacological treatment of acute venous thromboembolism in children. Paediatr Drugs. 2020;22(4):385\u2013397. https:\/\/doi.org\/10.1007\/s40272-020-00403-5 . PMID: 32519267.","DOI":"10.1007\/s40272-020-00403-5"},{"issue":"7","key":"822_CR18","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/jth.14813","volume":"18","author":"G Young","year":"2020","unstructured":"Young G, Lensing AWA, Monagle P, et al. Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation. J Thromb Haemost. 2020;18(7):1672\u201385. https:\/\/doi.org\/10.1111\/jth.14813.","journal-title":"J Thromb Haemost"},{"issue":"24","key":"822_CR19","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1182\/bloodadvances.2020003244","volume":"4","author":"P Connor","year":"2020","unstructured":"Connor P, van S\u00e1nchez M, Lensing AWA, et al. Safety and efficacy of Rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT). Blood Adv. 2020;4(24):6250\u20138. https:\/\/doi.org\/10.1182\/bloodadvances.2020003244.","journal-title":"Blood Adv"},{"issue":"8","key":"822_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/MBC.0000000000000772","volume":"29","author":"M Bordbar","year":"2018","unstructured":"Bordbar M, Haghpanah S, Dabbagh A, et al. Thrombosis in pediatric malignancy: a review and future perspectives with focus on management. Blood Coagul Fibrinolysis. 2018;29(8):689\u201395. https:\/\/doi.org\/10.1097\/MBC.0000000000000772.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"22","key":"822_CR21","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1182\/bloodadvances.2018024786","volume":"2","author":"P Monagle","year":"2018","unstructured":"Monagle P, Cuello CA, Augustine C, et al. American society of hematology 2018 guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018;2(22):3292\u2013316. https:\/\/doi.org\/10.1182\/bloodadvances.2018024786.","journal-title":"Blood Adv"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-025-00822-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00822-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00822-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:02:59Z","timestamp":1767909779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12959-025-00822-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["822"],"URL":"https:\/\/doi.org\/10.1186\/s12959-025-00822-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7201079\/v1","asserted-by":"object"}]},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethics Committee of the GWCMC (IRB No.2018022205, 2017102307, 2015020936, and 2019\u201304700), and conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from the patients or their legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}